Respiratory Physiology and Pathophysiology


37
Respiratory Physiology and Pathophysiology


Carolyn L. Kerr1 and Francisco J. Teixeira‐Neto2


1 Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada


2 Faculdade de Medicina Veterinária e Zootecnia, Universidade Estadual Paulista (UNESP), Botucatu, Brazil


Introduction


Maintenance of adequate respiratory function is a principal requirement for safe anesthesia. The respiratory system is responsible for eliminating carbon dioxide (CO2) via adjustments in alveolar ventilation per minute (V̇A), and for transferring oxygen from the alveoli to mixed venous blood (pulmonary artery blood) at the pulmonary capillary level. In conscious resting, mammals breathing air (fraction of inspired oxygen [FIO2] of 0.21) at sea level, CO2 partial pressure in arterial blood (PaCO2), and oxygen partial pressure in arterial blood (PaO2) usually range from 35 to 45 mmHg and from 90 to 110 mmHg, respectively, with some variation among species (Table 37.1). These gas partial pressures reflect adequate CO2 elimination and oxygen uptake to meet tissue metabolic requirements in normal patients at rest.


During general anesthesia, there is a tendency for PaO2 to be lower and PaCO2 to be elevated above that observed in the same species while conscious and breathing the same FIO2 [15]. Depending on the species and health of the individual patient, sedation alone may also result in deterioration of normal gas exchange [68]. Alteration in the efficacy of the gas exchange associated with sedation and/or general anesthesia results from changes in V̇A, pulmonary perfusion (Q̇), or alveolar ventilation–perfusion ratios (V̇A/Q̇) within the lung. Numerous factors, including species, influence the degree and nature of lung dysfunction in the perioperative period. However, within a species, the degree of change in lung function associated with anesthesia is significantly greater in individuals with underlying respiratory disease.


Strategies employed to manage the changes in respiratory function associated with sedation and general anesthesia include increasing the FIO2 delivered to a patient, establishing an artificial airway, and supporting ventilation through mechanical means. In certain instances, pharmaceutical interventions are warranted to address either underlying conditions or counter the side‐effects of diagnostic or therapeutic interventions. Further details regarding current strategies used to support veterinary patients’ respiratory function during anesthesia are provided in Chapter 38. While many strategies used in veterinary anesthesia are also employed in humans, veterinary species differ in terms of lung structure, body size, and the circumstances in which they are anesthetized. As such, it is important to consider the evidence surrounding the risks and benefits of the various interventions in the veterinary context as the goals and means to achieve them may be different than in humans. While perioperative morbidity and mortality are clearly linked to respiratory dysfunction, with appropriate interventions, the risks can be minimized, and outcomes optimized.


This chapter aims to provide a review of respiratory physiology with emphasis on pathophysiological changes in respiratory function associated with sedation and general anesthesia. Several excellent reviews of basic respiratory physiology exist, and the reader is encouraged to consult these works for further detail [9,10].


Key concepts and lung volumes


The primary function of the respiratory system is to eliminate CO2 produced by cell metabolism to the atmosphere and to transfer oxygen from the atmosphere to deoxygenated blood. Other functions include regulation of acid–base balance, via adjustment of CO2 partial pressure (PCO2) in blood; defense against pollutants and microorganisms that may be inhaled; and metabolism of vasoactive peptides by enzymes in lung cells (e.g., bradykinin and angiotensin).


Respiration is the total process whereby oxygen is supplied to and used by cells and CO2 is eliminated by means of partial pressure gradients. It is dependent on the integrated action of the respiratory and cardiovascular systems. Ventilation is the movement of gas in and out of the lungs. The ventilatory requirement for homeostasis varies with metabolic rate, and therefore varies with the animal species, age, body mass, level of activity, body temperature, and depth of anesthesia.


Table 37.1 Arterial blood gas and acid–base values for various species.































































































































































































Species Body weight (kg) n Conditions pHa PaCO2 (mmHg) PaO2 (mmHg) HCO3(mEq/L) Reference
Rat 0.207 10 Awake, chronic catheter 7.44 32.7
21.5 [11]
0.305 8 Awake, prone, chronic catheter 7.467 39.8
28.7 [12]
Rabbit 3.1 NS Awake, catheter 7.388 32.8 86 21 [13]
3.5 20 Awake, catheter 7.47 28.5 89.2 20.2 [14]
Cat 2.5–5.1 8 Unsedated, chronic catheter, prone 7.41 28.0 108 18 [15]
3–8 10 Unsedated, not restrained, chronic catheter 7.426 32.5 108 22.1 [16]
Dog 18.8 8 Unsedated, chronic trach/catheter, standing 7.383 39.0 103.8 22.1 [17]
12.2 22 Chronic catheters, lateral recumbency 7.40 35 102 21 [18]
Sheep 33 NS Awake, catheter 7.44 40.9 96 27.6 [13]
24.5 11 Unsedated, prone, carotid loop 7.48 33 92
[19]
Goat 18 6 Unsedated, standing 7.46 36.5 101
[20]
47.6 6 Unsedated, standing, catheter 7.45 35.3 94.5 24.1 [21]
46.6 6 Unsedated, standing 7.45 41.1 87.1 27.6 [22]
Calf 31–57 4 Standing, unsedated, aortic catheter 7.39 40 81 24 [23]
48–66 20 Unanesthetized, catheter 7.37 42.8 93.6 23.6 [24]
Cow 517 7 Awake, unsedated, standing 7.40 39.6 83.1 24.4 [25]
641 7 Awake, unsedated, standing 7.435 38.7 95.1 25.5 a
Horse 402 6 Awake, unsedated, standing 7.39 41.1 80.7 24.5 [25]
Pony 147 19 Standing, aortic catheter 7.40 40 88.7 24.4 [26]

n, sample size; NS, not specified; trach, tracheostomy.


a Warren R and McDonell WN; unpublished observations.


The volume of gas within the respiratory system is subdivided into four different volumes. Occasionally, it is desirable to consider two or more of the volumes together. Such combinations are termed “pulmonary capacities” (Fig. 37.1):



  1. Tidal volume (VT) is the volume of air that moves in and out of the respiratory system (conducting airways and alveoli) in one breath.
  2. Inspiratory reserve volume (IRV) is the volume of air that can be inspired over and above the normal VT.
  3. Expiratory reserve volume (ERV) is the amount of air that can be expired by forceful expiration after a normal expiration.
  4. Residual volume (RV) is the air remaining in the lungs after a maximal expiration.
  5. Inspiratory capacity (IC) is the VT plus the inspiratory reserve volume. This is the amount of air that can be inhaled starting after a normal expiration and distending the lungs to the maximum amount.
  6. Functional residual capacity (FRC) is the expiratory reserve volume plus the residual volume. This is the amount of air remaining in the lungs after a normal expiration. From a mechanical viewpoint, at FRC, the inward “pull” of the lungs due to their elasticity equals the outward “pull” of the chest wall.
  7. Vital capacity (VC) is the inspiratory reserve volume plus the VT plus the expiratory reserve volume. This is the maximum amount of air that can be expelled from the lungs after first filling them to their maximum capacity.
  8. Total lung capacity (TLC) is the inspiratory reserve volume plus the VT plus the expiratory reserve volume plus the residual volume, or the maximum volume to which the lungs can be expanded with the greatest possible inspiratory effort (or by full inflation to 30 cmH2O airway pressure when a patient is anesthetized).

Most of these volumes cannot be measured in conscious animals (Fig. 37.1), because to do so requires cooperation of the test subject. The TLC, FRC, and RV reported in mammalian species are summarized in Table 37.2. The TLC is generally estimated by inflation of the lung to pressures above 30 cmH2O in anesthetized animals. Values for TLC are reasonably similar among the domestic species when compared on a body‐weight basis, but the total volume varies from less than 2 mL in mice to over 45 L in horses and cows. The volume of gas remaining in the lungs at the end of a normal expiration (that is, the FRC) varies considerably among species and can rapidly change within an individual patient. Increased abdominal volume from any source (e.g., near‐term gravid uterus, bowel distension, obesity, or large abdominal tumor) will tend to move the diaphragm forward and lessen the FRC. Conversely, overnight fasting increased the FRC of ponies by about 16% [27]. Changes in body position, specifically, changing from standing to lateral or dorsal recumbency can significantly alter FRC in humans and in some veterinary species [2729]. Few actual measurements have been made of this phenomenon in relation to animals in health and disease, but the consequences for ventilation and arterial oxygenation in patients with severe lung disease or during anesthesia are consistent with a decrease in FRC.


Minute ventilation (V̇E), calculated as VT times breathing frequency (f), is the volume of air that moves in and out of the respiratory system (conducting airways and alveoli) over 1 min. It is only the fraction of V̇E that effectively ventilates the alveoli over 1 min (V̇A) that determines gas exchange.


Under normal conditions, V̇E is matched with CO2 production per minute (V̇CO2) to maintain PaCO2 within physiological ranges (Table 37.1). Factors that influence CO2 production and V̇E include species, age, body mass, level of activity, body temperature, and depth of anesthesia. Although basal metabolic rate and CO2 production per unit body mass are significantly higher in small mammals (mice and rats) than in large animal species (horses and cows), normal PaCO2 values are not substantially different. This is explained by the fact that V̇E (and V̇A) is significantly higher in mice and rats [32] than in horses and cows when indexed to body mass [25,3638]. The V̇E recorded in several animal species is presented in Table 37.3.

A diagram of lung volumes and capacities like tidal volume and functional residual capacity can be assessed in conscious animals other measurements may require cooperation or anesthesia.

Figure 37.1 Lung volumes and capacities. Only VT (obtained using a tightly fitting face mask attached to a pneumotachograph or by placing the animal in a whole‐body barometric plethysmography chamber) and FRC (obtained by an open‐circuit nitrogen washout technique) can be measured in conscious animals since the other measurements require cooperation of the subject being studied or general anesthesia.


Source: Adapted from Gallivan et al. [30]; Liu et al. [31].


Table 37.2 Lung volumes for various mammalian species.







































































































































Species Body weight (kg) n Conditions TLC FRC (mL/kg) RV (mL/kg) Reference
mL mL/kg
Mouse 0.020 NS Anesthetized 1.57 78.5 25.0 19.5 [32]
Rat 0.31 NS Anesthetized, prone 12.2 39.4 6.8 4.2 [32]
Rabbit 3.14 NS Anesthetized, supine 111 35.4 11.6 6.4 [32]
Cat 3.7 4 Anesthetized

17.8
[33]
Dog 18.6 6 Awake, prone 2090 112.4 53.6 16.7 [34]
9.2 140 Unsedated, 1‐year old

44.8
[35]
Sheep 24.5 4 Unsedated, prone, nasal endotracheal tube

45.3
[19]
Goat 46.4 6 Unsedated, standing, face mask

49.6
[22]
Cow 517 7 Awake, standing

39.4
[30]
537 5 Anesthetized, prone 45,377 84.5 31.9 16.1 [30]
Horse 485
Anesthetized, prone 44,800 92.4 36.3 19.0 [28]
402 6 Awake, standing

51.3
[30]
394 4 Anesthetized, prone, lung inflated to 35 cmH2O, starved 18 h 45,468 115.4 37.9
[30]
450–822 6 Conscious, standing

35.6
[27]
Pony 164–288 8 Conscious, standing

39.9
[27]

n, sample size; NS, not specified; TLC, total lung capacity; FRC, functional residual capacity; RV, residual volume.


Table 37.3 Breathing frequency (f), tidal volume (VT), and minute ventilation (V̇E) for various species.





































































































































































































































Species Mean body weight (kg) n Conditions f (breaths/min) VT E Reference
mL mL/kg mL/min mL/kg/min
Mouse 0.02 NS Awake, prone 163.4 0.15 7.78 24.5 1239 [32]
0.032 NS Anesthetized 109 0.18 5.63 21.0 720 [32]
Rat 0.113 NS Awake, prone 85.5 0.87 7.67 72.9 646 [32]
0.305 NS Awake, pleth 103 2.08 6.83 213 701 [32]
Cat 3.8 4 Unanesthetized, pleth 22 30 7.9 664 174 [39]
3.7 NS Anesthetized 30 34 9.2 960 310 [32]
Dog 18.6 6 Awake, prone, chronic trach, intubated 13 309 16.6 3818 205 [34]
18.8 8 Awake, standing, chronic trach, intubated 16.5 314 16.9 4963 264 [17]
Sheep 32–37 4 Awake, standing, mask 38 289 8.3 10,400 297 [40]
Goat 36.3 3 Awake, standing, mask 13.6 470 12.9 6313 174 [20]
Pig 46.4 6 Awake, standing, mask 26 483 10.4 11,900 256 [22]
47.6 6 Awake, standing, mask 17.6 602 12.6 10,540 221 [21]
12.9 4 Awake, standing 13.1 209 15.9 2731 208 [41]
Cow 517 Holstein 7 Awake, standing, mask 23.7 3676 7.1 85,977 166 [25]
405 Jersey 11 Awake, standing, mask 28.6 3360 8.3 94,870 234 [38]
Calf 43–73 Hereford 8 4–6 weeks old, standing, sling 26.7 403 15.1 10,290 385 [42]
Horse 402 6 Awake, standing, mask 11.8 4253 10.6 49,466 123 [25]
483 6 Awake, standing, mask 15.5 4860 10.1 74,600 154 [37]
486 15 Awake, standing, mask (some sedated) (mask VD not removed) 10 7300 15.0 79,000 163 [36]
Pony 147 19 Awake, standing, mask 19.0 1370 9.3 26,380 180 [26]

n, sample size; NS, not specified; pleth, whole‐body plethysmograph; trach, tracheostomy.


Respiratory function in conscious and anesthetized animals


When considering respiratory function and dysfunction in the clinical setting, it is useful to evaluate the respiratory system in terms of its major components: neural control, structures involved in achieving ventilation (upper airway and the bellows mechanism, including the thoracic wall and diaphragm), and lung parenchyma where the matching of ventilation and perfusion results in gas exchange (Fig. 37.2). Alterations of arterial blood gas values occur due to changes in (1) the neural control of ventilation by sedative, opioid, or anesthetic depression and/or central nervous system (CNS) disease; (2) upper airway or lower airway patency by muscle relaxation or spasm; or (3) the bellows mechanism of the thorax through decreased inspiratory muscle tone (diaphragm and intercostal muscles) by anesthetic drugs, neuromuscular paralysis, space‐occupying lesions of the thorax, or a change in the diaphragm shape, location, or function; and (4) the parenchyma, such as an abnormal alveolar–capillary membrane or less than optimal matching between V̇A and Q̇.


Neural control of ventilation


The movement of air in and out of the lungs in a rhythmic ventilatory pattern is determined by a complex network of neurons located in the brainstem (medulla oblongata and pons), which receive neural input from central and peripheral chemoreceptors, the cerebral cortex, and from pulmonary receptors (Fig. 37.3) [44]. Respiratory neurons include those located in the pontine respiratory group (lateral parabrachial and Kölliker–Fuse areas) and several medullary areas, most notably the retrotrapezoid nucleus, the Bötzinger and preBötzinger complexes, the rostral (nucleus ambiguous) and caudal ventral respiratory groups (nucleus parambigualis and nucleus retroambigualis), and a dorsal respiratory group of neurons located in the nucleus tractus solitarius [44]. Current understanding of respiratory processing and control mechanisms are described in detail elsewhere [4345]. Normal respiratory rhythmicity originates from neuronal activity in a subset of respiratory neurons, referred to as the “central pattern generator,” which initiates inspiration by increasing efferent nerve signals to the external intercostal muscles and diaphragm. The intercostal nerves, which originate from the ventral branch of spinal thoracic nerves, provide motor innervation to the intercostal muscles; while the phrenic nerve, which originates from branches of cervical nerves (between the fourth and seventh cervical vertebrae), is responsible for the contraction of the diaphragm. Inspiration, which is an active process that involves contraction of external intercostal muscles and diaphragm, is terminated through inhibition of the inspiratory neurons by the pontine respiratory group, also known as the “pneumotaxic center,” and by afferent nerve impulses originating from pulmonary stretch receptors. In most species, expiration occurs passively, without any muscular effort (equidae being a notable exception). In some circumstances, such as during exercise, expiratory neurons in the medulla can become activated, resulting in contraction of the expiratory muscles (abdominal and internal intercostal muscles) [43,46]. Respiratory control mechanisms monitor the chemical composition of blood (pH, PaCO2, and PaO2), the effort exerted by respiratory muscles, and the presence of foreign material within the airway, providing input to the brainstem to alter the bronchomotor tone, duration of inspiration, airflow velocity on inspiration and expiration, and respiratory frequency.

A diagram of lung function neural control, bellows mechanism, gas matching includes minute volume, respiratory frequency, tidal volume, airway dead space, alveolar tidal volume, oxygen, and carbon dioxide partial pressures.

Figure 37.2 Diagrammatic representation of the neural control, bellows mechanism (diaphragm and thoracic wall), and matching of pulmonary artery (mixed venous) blood and alveolar gas in the lung under ideal conditions. Minute volume (V̇E), respiratory frequency (f), tidal volume (VT), airway deadspace (normal upper V Subscript normal upper D Sub Subscript a w) (colored blue), alveolar tidal volume (normal upper V Subscript normal upper T Sub Subscript a l v) (colored yellow), and representative inspired (PI), alveolar (PA), mixed venous (Pnormal v overbar), end‐capillary (Pc′), and arterial (Pa) partial pressures of oxygen and carbon dioxide are also illustrated (see the text for a detailed explanation). *Respiratory quotient (R) represents the relative ratio of carbon dioxide production to oxygen consumption (assumed to be 0.9 in conscious healthy dogs).


Source: Adapted from Walters et al. [43].

A diagram of neural control of ventilation medullary and pontine respiratory centers coordinate respiratory muscle inputs from chemoreceptors, cortex, and receptors adjust pulmonary ventilation.

Figure 37.3 Diagrammatic representation of the neural control of ventilation. The medullary respiratory center receives multiple inputs and coordinates activity of respiratory muscles and adjusts pulmonary ventilation (see text for detailed explanation).


Source: Adapted from Lyons and Kevin [46].

Two graphs. a. A graph shows Ve versus partial pressure of hypercapnia E in conscious horses using partial pressure as an indicator. b. A graph shows the percent change in Ve from control versus inspired oxygen concentration of oxygen concentration changes E in conscious horses with and without acepromazine.

Figure 37.4 A. Effects of hypercapnia on V̇E in conscious horses. End‐tidal CO2 partial pressure (PETCO2) was used as an indicator of hypercapnia induced by CO2 rebreathing. B. Effects of changes in inspired oxygen concentration on percent changes in V̇E from baseline (inspired oxygen = 21%) recorded in conscious horses (control), and in horses that received a tranquilizer (acepromazine).


Source: Adapted from Gauvreau et al. [48]; Muir and Hamlin [50].


Central and peripheral chemoreceptors provide the major afferent input to the respiratory neurons in the medulla and pons as illustrated in Fig. 37.3 [4446]. The central chemoreceptors, located primarily on the ventral surface of the medulla, as well as in other locations within the CNS, are responsible for maintaining a tonic ventilatory drive at normal baseline PaCO2 levels and for increasing V̇E in response to increasing PaCO2 levels [47]. The effect of PaCO2 on central chemoreceptor activity occurs indirectly via changes in cerebrospinal fluid (CSF) hydrogen ion concentration (pH) as CO2 readily crosses the blood–brain barrier and reacts with water to form carbonic acid (H2CO3), which in turn dissociates into H+ and bicarbonate (HCO3) (Fig. 37.3). The CSF exhibits poor buffering capacity and any change in PCO2 within the CNS is quickly reflected as a change in pH [44,46]. The correlation between V̇E and progressively increasing CO2 levels in conscious horses is shown in Fig. 37.4A. Anesthetic drugs alter the relationship between V̇E and PaCO2 by decreasing central chemoreceptor sensitivity to increasing CO2 levels and by inhibiting neuronal activity within the respiratory center of the brainstem.


Peripheral chemoreceptors are primarily responsible for the ventilatory response to decreases in PaO2 (Fig. 37.3) [44]. These receptors respond faster than central chemoreceptors and are located within the highly vascular carotid and aortic bodies, although the role of the chemoreceptors in the aortic bodies in mature animals is believed to play a less significant role [44]. As PaO2 levels fall, peripheral chemoreceptors increase input to the respiratory center in the brainstem to increase V̇E, a response referred to as the “hypoxic ventilatory drive.” Peripheral chemoreceptor also play an important role in the maintenance of normal PaCO2 and arterial pH and are responsible for 30–50% of the tonic drive to ventilate. In sheep, goats, calves, pigs, and ponies, carotid body denervation causes hypoventilation, hypoxemia, and hypercapnia [23,41].


In general, there is tight physiologic control over PaCO2 with a quasi‐linear relationship between V̇E and PaCO2 (and end‐tidal CO2 partial pressure [PETCO2]), with higher CO2 levels increasing V̇E as illustrated in Fig. 37.4A [48]. Species differences in response to progressive increases in PaCO2 or PETCO2 induced by increasing inspired CO2 exist, with horses being slightly less responsive and burrowing or diving animals being much less responsive than humans [4850]. Unlike the quasi‐linear relationship between V̇E and increasing CO2 levels, the change in V̇E evoked by changes in PaO2 is curvilinear. While V̇E remains relatively constant with PaO2 values above 70 mmHg, an exponential increase in V̇E occurs as PaO2 falls below 60–70 mmHg in mature animals [44,46,49]. As illustrated in Fig. 37.4B, when the FIO2 in conscious horses was decreased from approximately 1 (100% inspired oxygen concentration) to 0.16 (16% inspired oxygen concentration), there was no substantial change in V̇E; however, as FIO2 was decreased below 0.16, an inspired oxygen concentration that would result in PaO2 < 60 mmHg, V̇E increased exponentially [50].


Metabolic acid–base disturbances trigger a compensatory response in ventilation through peripheral chemoreceptors. A decrease in plasma pH originating from non‐respiratory causes stimulates peripheral chemoreceptors and increases V̇E. The decrease in PaCO2 secondary to the increase in ventilatory drive reduces the impact of metabolic acidosis on blood/extracellular pH. The compensatory decrease in PaCO2 in animals with metabolic acidosis is self‐limiting because of a decrease in central chemoreceptor activity associated with the alkalinization of CSF pH, which limits further reductions in PaCO2. Therefore, respiratory compensation of metabolic acidosis may only partially offset the impact of the metabolic acid–base disturbance on pH [46,51]. The decreased V̇E and compensatory increase in PaCO2 during metabolic alkalosis is also limited because rising PCO2 levels within the CNS increase the ventilatory drive [51].


The respiratory compensation of metabolic acid–base disturbances can be estimated in dogs. To date, there is limited data to allow calculation of the expected respiratory compensation of metabolic acid–base disturbances in cats, but it appears that the feline species have a limited ability to reduce the impact of metabolic acidosis on pH through an increase in pulmonary ventilation [51]. In dogs with primary metabolic acidosis, for each mEq/L of decrease in plasma HCO3 from normal values (e.g., 20 mEq/L), a compensatory decrease in PaCO2 of 0.7 mmHg is expected to occur [51,52]. Changes in PaCO2 of the same magnitude but in an opposite direction occur during metabolic alkalosis. Calculating the expected respiratory compensation to metabolic acid–base derangements is useful to differentiate simple from mixed acid–base disturbances and the reader is referred to the specialized literature for further details [51,52]. From an anesthesiologist’s perspective, it is important to understand that anesthetic drugs may decrease central and peripheral chemoreceptor activity, increasing PaCO2 and inhibiting the respiratory compensation to metabolic acidosis.


The cerebral cortex also provides input to the medullary respiratory center, mediating behavioral/voluntary changes in pulmonary ventilation (Fig. 37.3). Behavioral changes such as fear, anxiety, excitement, and pain are thought to be particularly important in small animal species and will often increase ventilatory drive and cause hypocapnia (low PaCO2)/primary respiratory alkalosis because of increased V̇E and V̇A [53]. Heat stress/hyperthermia may also increase the ventilatory drive, particularly in animals with limited ability to sweat through the skin, such as dogs. In these species, panting is an important thermoregulatory mechanism. Panting is characterized by a controlled increase in f and a decrease in VT with the purpose of increasing evaporative heat loss through the upper airways [54]. Although V̇E is increased in animals that are panting, such change results mainly from increased deadspace ventilation (increased ventilation to the conducting airways). Therefore, PaCO2 may be close to normal because the decrease in VT prevents V̇A from increasing.


Pulmonary inputs to the medullary respiratory center include the pulmonary stretch receptors (also known as “slowly adapting stretch receptors”), J receptors, and irritant receptors (also known as “rapidly adapting stretch receptors”) (Fig. 37.3) [44,46]. The pulmonary stretch receptors, located in the smooth muscle of the airways (trachea and bronchi) [55], are stimulated by distension of airway smooth muscle (enlargement of airway cross‐sectional area) as lung volume increases during inspiration [56]. As there is an increase in the frequency of depolarization from these receptors caused by the conditions described above, a negative feedback mechanism (the Hering–Breuer reflex) determines termination of inspiration and prevents lung over‐inflation [44,46]. Although the role of pulmonary stretch receptors in controlling inspiration in adult humans is now believed to be minor, in several veterinary species including dogs, cats, and rabbits, it appears to play a significant role in the regulation of VT [44,57]. The J receptors are nerve endings located in the pulmonary interstitium and the conducting airways. Stimulation of J receptors by inflammation results in rapid, shallow breathing, mucus production, and bronchoconstriction [44]. Irritant receptors are nerve endings located in the epithelial cells of the conducting airways that are activated by noxious stimuli such as gases/chemicals and suspended particles [44]. Activation of these receptors will alter the ventilatory rhythmic pattern and may lead to rapid/shallow breathing. Sniffing and sneezing are caused by the presence of irritants in the nasal cavity, whereas stimulation of laryngeal and pharyngeal irritant receptors may cause cough, mucus secretion, or, in severe situations, laryngospasm, bronchospasm, and apnea.


Pulmonary ventilation


Physics of respiratory gases and the alveolar gas equation


Respiratory gases (oxygen, CO2, and nitrogen) can be measured as percent of total volume represented by each gas in the mixture (%) or according to their partial pressure in millimeters of mercury (mmHg) or kilopascals (1 kPa = 7.5 mmHg). Gases dissolve in fluids and diffuse across membranes (e.g., alveolar–capillary membrane) according to their partial pressures [58]. Dalton’s law states that the total partial pressure of a gas mixture equals the sum of the partial pressure of each gas. The partial pressure of each gas is calculated by multiplying the percent volume of each gas in the mixture by the barometric pressure (PB), that is, the pressure exerted by the atmosphere, and is expressed in mmHg or kPa (Fig. 37.5). Because the degree of collision among gas molecules is influenced by the gravitational forces exerted by the earth, the partial pressure of a single gas or gas mixture will vary according to the altitude in relation to sea level [58]. While the partial pressure of a gas or gas mixture decreases in proportion to the decrease in barometric pressure at higher altitudes, the percent volume of gas in the mixture remains constant with changes in altitude and barometric pressure. As such, FIO2 is the same at sea level or the top of Mount Everest (21%), the highest peak on earth (8848 meters above sea level). However, because PB at Mount Everest is about one‐third of that at sea level (253 mmHg and 760 mmHg, respectively), oxygen partial pressure in inspired gas (PIO2) at this altitude will be markedly low (53 mmHg, calculated as FIO2 × PB), leading to a degree of hypoxemia that is incompatible with life. While extremely high altitudes (above 5500 meters or 18,000 feet) generally cannot sustain developed forms of life due to the low PIO2, another more realistic example of the impact of altitude on inspired gases is illustrated in Fig. 37.5. Compared to Rio de Janeiro (Brazil), located at sea level, the PIO2 in Fort Collins (United States), located 1525 meters above sea level, is reduced from 160 mmHg to 134 mmHg due to altitude. Oxygen partial pressure in alveolar gas (PAO2), calculated on the basis of the alveolar gas equation, will be approximately 105 mmHg and 85 mmHg at sea level and an altitude of 1525 meters, respectively. Assuming that the alveolar to arterial oxygen gradient (P(a‐a)O2) is normally between 5 and 15 mmHg, normal PaO2 levels in Rio de Janeiro and Fort Collins are estimated to be approximately 95–100 mmHg and 75–80 mmHg, respectively.

A diagram of altitude changes on gas concentrations in Rio de Janeiro, brazil, and Fort Collins, united states of america at 1525 meters above sea level.

Figure 37.5 Diagrammatic representation of the influence of variations in altitude on ambient air assuming negligible air humidity (i.e., water vapor partial pressure = zero) (see text for explanation). PIO2, inspired partial pressure of oxygen; PIN2, inspired partial pressure of nitrogen; PB, barometric pressure.


Table 37.4 Composition of respiratory gases expressed as percent volume (%) and as partial pressure (mmHg) at sea level for air and 100% oxygen.


Source: Data taken from Hlastala [58].






































































Gas Inspired gas (breathing air):
= 9 mmHg a
Alveolar gas (breathing air):
= 47 mmHg b
Percent volume Partial pressure Percent volume Partial pressure
Nitrogen 79% 593 mmHg 79% 563 mmHg
Oxygen 20.95% 157 mmHg 15.3% 109 mmHg
Carbon dioxide 0.04% 0.3 mmHg 5.7% 41 mmHg
Total sumc 100% 751 mmHg 100% 713 mmHg
Gas Inspired gas (breathing 100% oxygen):
= 0 mmHg
Alveolar gas (breathing 100% oxygen):
= 47 mmHg b
Percent volume Partial pressure Percent volume Partial pressure
Nitrogen 3% 23 mmHg 3% 21 mmHg
Oxygen 97% 737 mmHg 91.3% 651 mmHg
Carbon dioxide 5.7% 41 mmHg
Total sumc 100% 760 mmHg 100% 713 mmHg

a  Water vapor partial pressure assuming 51% relative humidity at 20 °C ambient temperature.


b  Water vapor partial pressure assuming alveolar gas fully saturated with water and warmed (37 °C) after passing through the conducting airways.


c  Total sum of partial pressures will equal atmospheric pressure at sea level (760 mmHg) if water vapor pressure is added.


The water vapor partial pressure (upper P Subscript upper H 2 upper O) decreases the PB and should be subtracted from the altitude‐based barometric pressure if ambient air humidity is elevated. In the presence of water vapor, the sum of the partial pressures of a gas mixture should be equal to PB minus upper P Subscript upper H 2 upper O (Table 37.4). For simplicity, it is typically assumed that water vapor partial pressure is zero in ambient air and the sum of partial pressure of gases equals the barometric pressure at a given altitude (Table. 37.4). While water vapor partial pressure in inspired gas is probably zero in a patient receiving 100% medical oxygen without humidification, this simplification may stray from reality if relative air humidity and ambient temperature are elevated. If the relative air humidity is 51%, water vapor pressure of ambient air is 9 mmHg at 20 °C [58].


The composition of alveolar gas differs from inspired dry air because, in addition to oxygen and nitrogen, it contains saturated water vapor and CO2 that diffused out of pulmonary capillary blood, according to the alveolar gas equation (Fig. 37.2, Table 37.4):


normal upper P Subscript normal upper A Baseline normal upper O 2 equals normal upper F Subscript normal upper I Baseline normal upper O 2 times left-parenthesis normal upper P Subscript normal upper B Baseline minus normal upper P Subscript normal upper H 2 normal upper O Baseline right-parenthesis minus StartFraction normal upper P Subscript normal upper A Baseline upper C upper O 2 Over normal upper R EndFraction

Where PAO2 is oxygen partial pressure in alveolar gas, FIO2 is the fraction of inspired oxygen, PB is the barometric pressure, upper P Subscript upper H 2 upper O is the water vapor pressure, PACO2 is the alveolar CO2 partial pressure, and R is the respiratory quotient. As inspired gases are warmed and humidified after passing through the conducting airways, water vapor partial pressure increases to 47 mmHg at 37 °C (Fig. 37.2, Table 37.4). Carbon dioxide is highly diffusible across the alveolar–capillary membrane; therefore, PACO2 is assumed to be equal to PaCO2. However, to account for the metabolic rate, PACO2 should be divided by the R, that is, the ratio between CO2 production per minute (V̇CO2) and oxygen consumption per minute (V̇O2), as follows:


normal upper R equals StartFraction ModifyingAbove upper V With dot upper C upper O 2 Over ModifyingAbove upper V With dot upper O 2 EndFraction

The respiratory quotient is influenced by the diet/source of energy metabolism and varies with the percentage of carbohydrates, proteins, and fats being oxidized. Oxidative metabolism of carbohydrates, proteins, and fats results in R values of 1, 0.8, and 0.7, respectively [58]. The reason for this difference is that when oxygen fuels carbohydrate metabolism, one molecule of CO2 is formed for each molecule of oxygen consumed; during oxidative metabolism of fats, a large share of the oxygen combines with hydrogen atoms from the fats to form water instead of CO2. In humans consuming a Western diet, R has been determined to be 0.8 while studies in healthy conscious dogs report an R‐value of 0.9 [43]. The respiratory quotient can be altered by species, breed, nutritional state, hormonal circadian rhythm, and level of activity. Because of changes in the energy metabolism, R values ranging from 0.7 to 0.8 have been reported in critically ill dogs [59].


Kinetics of carbon dioxide elimination


The ideal gas exchange between pulmonary capillary blood and the alveoli is illustrated in Fig. 37.2. As the CO2 in mixed venous blood (CO2 partial pressure in mixed venous blood [Pnormal v overbarCO2]) reaches the pulmonary capillaries, it equilibrates with PACO2. The rate of CO2 removal from the alveoli to ambient air, and consequently the PACO2 and the CO2 partial pressure in end‐pulmonary capillary blood (Pc´CO2), is determined by the volume of air flowing in and out of alveoli over 1 min, that is, V̇A [9]. The PaCO2, which averages CO2 of the end‐capillary blood from all alveoli, indicates the adequacy of V̇A. It is important to understand the variables that influence CO2 removal to manage V̇A and PaCO2 in the perianesthetic setting.


The flow of gas in and out of the lungs is an essential component of gas exchange between alveoli and the pulmonary capillary blood. As explained before, V̇E, is determined by the breathing frequency (f ) and by the volume of gas that enters and leaves the mouth or nostrils in each breath, that is the tidal volume (VT) (Fig. 37.2, Table 37.3).


ModifyingAbove upper V With dot Subscript normal upper E Baseline equals f times normal upper V Subscript normal upper T

Gas exchange takes place only at the level of the alveolar–capillary barrier, more specifically in alveoli that are ventilated and perfused. Areas of the respiratory tract that receive ventilation but that do not participate in gas exchange, are referred to as “deadspace.” Because the upper airways and tracheobronchial tree do not participate in gas exchange, the relative volume necessary to fill these structures during tidal breathing is termed “airway deadspace” (normal upper V Subscript normal upper D Sub Subscript a w). The conducting airways are not the only component of the respiratory system responsible for deadspace ventilation, however, ventilated but not perfused alveoli also contribute to deadspace. The volume of these alveolar units is referred to as “alveolar deadspace” (normal upper V Subscript normal upper D Sub Subscript a l v). “Physiologic deadspace” (normal upper V Subscript normal upper D Sub Subscript p h y s) is the total deadspace volume, which includes normal upper V Subscript normal upper D Sub Subscript a w and normal upper V Subscript normal upper D Sub Subscript a l v (Fig. 37.6A):


normal upper V Subscript normal upper D Sub Subscript p h y s Baseline equals normal upper V Subscript normal upper D Sub Subscript a w Baseline plus normal upper V Subscript normal upper D Sub Subscript a l v

Although V̇E is commonly measured to evaluate pulmonary ventilation, the important factor in pulmonary gas exchange is the rate at which alveolar air is exchanged with atmospheric air. Alveolar ventilation per minute (V̇A) is described by:


ModifyingAbove normal upper V With dot Subscript normal upper A Baseline equals left-parenthesis normal upper V Subscript normal upper T Baseline minus normal upper V Subscript normal upper D Sub Subscript p h y s Subscript Baseline right-parenthesis times f o r ModifyingAbove normal upper V With dot Subscript normal upper A Baseline equals ModifyingAbove normal upper V With dot Subscript normal upper E Baseline minus ModifyingAbove normal upper V With dot Subscript normal upper D Sub Subscript p h y s
a. A diagram of ventilation-to-perfusion relationships and carbon dioxide elimination kinetics in dead space ventilation. b and c. Two graphs show carbon dioxide versus expired partial pressure changes during volumetric capnography.

Figure 37.6 A. Diagrammatic representation of ventilation‐to‐perfusion relationships in relation to deadspace ventilation and the kinetics of carbon dioxide elimination. B. and C. Graphic representation of expired carbon dioxide partial pressure changes in relation to expired VT (volumetric capnography) (see the text for detailed explanation).



The formula above accounts for the volume of gas that enters and leaves the physiologic deadspace per minute (ModifyingAbove normal upper V With dot Subscript normal upper D Sub Subscript p h y s). With the use of volumetric capnography (further discussed below in this section), V̇A can be measured. Alternatively, the alveolar ventilation equation can be used to quantitate V̇A. In this equation, V̇CO2 is CO2 production per minute, PACO2 is the CO2 partial pressure in the alveolus, which is assumed to be equal to PaCO2, and K is a constant:


ModifyingAbove normal upper V With dot Subscript normal upper A Baseline equals upper K times StartFraction ModifyingAbove normal upper V With dot upper C upper O Subscript 2 Baseline Over upper P a upper C upper O 2 EndFraction

From this equation, it is evident that V̇A is inversely correlated with PaCO2. If V̇A is reduced by 50%, and V̇CO2 is unchanged (stable metabolism), PaCO2 will double and vice versa. Pulmonary ventilation (V̇E and V̇A) in the resting state should match the CO2 production at the basal metabolic rate, which may vary among animal species and breeds [60]. Because energy expenditure and basal metabolic rate are significantly higher at birth and progressively decrease as aging occurs [60], V̇E and V̇A are significantly higher in neonatal and pediatric patients than in adult animals. The clinical implication of higher V̇E and V̇A in younger patients is that respiratory depression caused by anesthetic agents can rapidly lead to severe hypercapnia and hypoxemia in these individuals.


Based on the second formula above (V̇A = V̇EModifyingAbove normal upper V With dot Subscript normal upper D Sub Subscript p h y s), isolating V̇E on one side of the equation shows that V̇E is the sum of ModifyingAbove normal upper V With dot Subscript normal upper D Sub Subscript p h y s and V̇A. However, during a single breath, gas exchange will depend on the fraction of VT that goes beyond the normal upper V Subscript normal upper D Sub Subscript p h y s, and effectively ventilates alveoli that are perfused. While both fractions of a VT are useful to consider as independent variables, over time, there is some mixing between the gas in the normal upper V Subscript normal upper D Sub Subscript a w and the alveolar gas due to diffusion of gases, a phenomenon facilitated by the movement created by the beating heart [61]. This “mixing” action probably explains why PaCO2 levels are usually not all that elevated in smaller dogs or cats showing a very shallow tachypneic breathing pattern wherein VT must be near normal upper V Subscript normal upper D Sub Subscript a w. It probably also explains why insufflation of 15 L/min oxygen deep into the trachea in an apneic horse will maintain PaO2 values in the 50–60 mmHg range (Dr. Wayne McDonell, personal observation).


Experimentally, normal upper V Subscript normal upper D Sub Subscript p h y s has been evaluated in animals using several techniques that are influenced to varying degrees by pulmonary ventilation and perfusion abnormalities (V̇A/Q̇ mismatch and shunt). As clinicians and researchers, it is important to consider the methodology and the factors influencing the measurement as it may alter the interpretation of the results [6264]. Initial studies in humans measured normal upper V Subscript normal upper D Sub Subscript a w using the single‐breath nitrogen washout test (Fowler’s technique), which involves plotting the partial pressure of nitrogen in expired gas of a single breath after a maximal voluntary inspiration of 100% oxygen [9,65]. However, the Fowler technique is technically challenging to perform in conscious animals due to the need for voluntary maximum inspiration.


Physiologic deadspace to tidal volume ratio (normal upper V Subscript normal upper D Sub Subscript p h y s/VT), which is the proportion of VT that does not contribute to gas exchange, has been determined through application of the Bohr equation:


StartFraction normal upper V Subscript normal upper D Sub Subscript p h y s Subscript Baseline Over normal upper V Subscript normal upper T Baseline EndFraction equals StartFraction normal upper P Subscript normal upper A Baseline upper C upper O 2 minus normal upper P Subscript normal upper E Baseline upper C upper O 2 Over normal upper P Subscript normal upper A Baseline upper C upper O 2 EndFraction

In this equation, PACO2 represents mean alveolar CO2 partial pressure and PECO2 is the average CO2 partial pressure in mixed expired gas collected during a single breath. Effectively, the greater the amount of gas from alveolar units that are ventilated and non‐perfused (normal upper V Subscript normal upper D Sub Subscript a l v) that is added to the exhaled breath, the greater the reduction of PECO2 below PACO2, thereby indicating a greater proportion of deadspace ventilation in relation to VT. However, before the advent of volumetric capnography, measurement of PACO2 required complex methodology applicable only to the research setting (for example, multiple inert gas elimination technique) [25,66]. Therefore, PaCO2 has been substituted for PACO2 in the calculation (Bohr–Enghoff equation) as follows:


StartFraction normal upper V Subscript normal upper D Sub Subscript p h y s Subscript Baseline Over normal upper V Subscript normal upper T Baseline EndFraction equals StartFraction upper P a upper C upper O 2 minus normal upper P Subscript normal upper E Baseline upper C upper O 2 Over upper P a upper C upper O 2 EndFraction

The presence of perfused non‐ventilated alveoli (shunt) or alveoli with low ventilation‐to‐perfusion (V̇A/Q̇) ratio does not increase true normal upper V Subscript normal upper D Sub Subscript a l v; however, the calculated normal upper V Subscript normal upper D Sub Subscript p h y s/VT ratio using the Enghoff modification of the Bohr equation is impacted by ventilation‐to‐perfusion inequalities caused by shunt and areas of low V̇A/Q̇ ratio as these abnormalities will add CO2‐rich mixed venous blood to arterial blood, increasing PaCO2, and resulting in greater overestimation of normal upper V Subscript normal upper D Sub Subscript p h y s/VT by the Bohr–Enghoff equation. Specifically, any calculation that replaces PACO2 with PaCO2 will artificially increase the deadspace determination in the presence of poorly ventilated (low V̇A/Q̇ ratio) and non‐ventilated alveoli (shunt) due to rising PaCO2 levels, assuming constant VT [6264]. In patients with lower‐than‐expected PaO2 values in relation to the FIO2, the impact of shunt and low V̇A/Q̇ regions on gas exchange should be considered when applying these calculations to patient ventilatory management.


In addition to the Bohr–Enghoff normal upper V Subscript normal upper D Sub Subscript p h y s/VT, the alveolar deadspace fraction (normal upper V Subscript normal upper D Sub Subscript a l v/VT), that is the fraction of VT that ventilates non‐perfused alveoli, has been proposed to be estimated by replacing PECO2 with PETCO2 [67]:


StartFraction normal upper V Subscript normal upper D Sub Subscript a l v Subscript Baseline Over normal upper V Subscript normal upper T Baseline EndFraction equals StartFraction upper P a upper C upper O 2 minus normal upper P Subscript upper E upper T Baseline upper C upper O 2 Over upper P a upper C upper O 2 EndFraction

Calculation of normal upper V Subscript normal upper D Sub Subscript a l v/VT as described above will result in a significantly smaller deadspace value as it reflects only a fraction of total (physiologic) deadspace [6264]. Under normal circumstances, PETCO2 is up to 5 mmHg lower than PaCO2 because of dilution of alveolar gas, which contains CO2, with gas from deadspace which does not contain CO2. As a simplification of the formula above, normal upper V Subscript normal upper D Sub Subscript a l v is considered to be increased if the arterial to end‐tidal CO2 gradient (P(a‐ET)CO2) is abnormally high. In this case, because PACO2 is replaced by PaCO2, normal upper V Subscript normal upper D Sub Subscript a l v/VT and P(a‐et)CO2 will also increase in the presence of V̇A/Q̇ mismatch caused by shunted flow and a low V̇A/Q̇ ratio leading to oxygenation impairment, in a similar way as the Bohr–Enghoff normal upper V Subscript normal upper D Sub Subscript p h y s/VT [68]. Therefore, in the presence of the above‐described conditions, an increase in normal upper V Subscript normal upper D Sub Subscript a l v/VT and P(a‐et)CO2 reflects an increase in the scatter of V̇A/Q̇ mismatch in the lung rather than only an increase in normal upper V Subscript normal upper D Sub Subscript a l v.


In the research setting, upper V Subscript upper D Sub Subscript p h y s/VT can be determined by collecting arterial blood gas samples to measure PaCO2 as an equivalent to PACO2 as well as collecting exhaled gases in a mixing chamber, or Douglas bag, to measure CO2 in mixed expired gas (PECO2) in large animals (horses and cows) and dogs [25,69]. More recently, with the introduction of volumetric capnography for monitoring patients during mechanical ventilation, upper V Subscript upper D Sub Subscript p h y s/VT can be more practically and reliably measured in intubated small animals [70]. Volumetric capnography is the graphic representation of expired CO2 versus expired VT measured using a capnograph and a pneumotachometer (device that measures flow over time) placed at the end of an endotracheal tube.


The diagram in Fig. 37.6A shows the composition of deadspace and its relationship with alveoli presenting different ventilation‐to‐perfusion ratios. If alveoli present an ideal ventilation‐to‐perfusion ratio (V̇A/Q̇ = 1), an equilibrium is established between deoxygenated (mixed venous) blood with higher CO2 content entering the pulmonary capillary and alveolar CO2 (PACO2). The mixed expired CO2 in each tidal breath reflects the average CO2 from alveoli that are effectively ventilated and perfused over a range of V̇A/Q̇ ratios, which contribute to CO2 elimination, and alveoli that are ventilated but not perfused (upper V Subscript upper D Sub Subscript a l v), which do not contribute to CO2 elimination. An increase in upper V Subscript upper D Sub Subscript a l v, lowers CO2 in mixed expired gas (PECO2) and increases the gradient between PACO2 (or PaCO2 according to the Bohr–Enghoff equation) and PECO2 [6264].


The kinetics of CO2 elimination assessed by the volumetric capnography curve has three distinct phases (Fig. 37.6B). Phase I represents exhaled gas from the upper airways, which does not contain CO2. Phase II represents expired gas from the lower portions of the airways mixed with CO2‐rich alveolar gas, which causes a rapid rise in CO2. Phase III is the expired volume that represents pure alveolar gas as the CO2 curve flattens and plateaus. The slope of phase III reflects the emptying of alveoli with different time constants. In patients with small airway disease/bronchoconstriction, or with lung disease, resistance to gas flow may differ substantially among alveolar units [71]. During expiration, alveoli where the conducting airways offer low resistance to gas flow empty first (“fast” alveoli), whereas poorly ventilated alveolar units due to increased resistance to gas flow take longer to empty. Because alveoli with different time constants differ in the speed they are emptied during expiration, the slope of phase III increases [71]. The area under the CO2 curve represents the total amount of CO2 exhaled during a single breath (VTCO2,br). The CO2 eliminated per minute, which is assumed to be equivalent to CO2 production per minute (V̇CO2), is calculated by multiplying the respiratory rate (f) by the VTCO2,br.


The airway–alveolar interface, identified as the inflection point of phase II, is the limit between exhaled gas from lower conducting airways (bronchioles) and CO2‐rich alveolar gas (Fig. 37.6C). The expired volume below and above the inflection point represents the airway deadspace (upper V Subscript upper D Sub Subscript a w) and the alveolar tidal volume (upper V Subscript upper T Sub Subscript a l v), respectively. The CO2 level at the midpoint of phase III slope, starting at the inflection point and ending at the end‐tidal partial pressure of CO2 (PETCO2), represents the average CO2 of all alveolar units (PACO2) [64,66,72]. Studies measuring PACO2 by the multiple inert gas elimination technique have validated PACO2 measured by volumetric capnography [66,72].


The area above the volumetric capnography curve, which reflects deadspace ventilation, shows that upper V Subscript upper D Sub Subscript p h y s (upper V Subscript upper D Sub Subscript a w + upper V Subscript upper D Sub Subscript a l v) calculations based on the Bohr equation (Fig. 37.7A) are overestimated when PaCO2 is used to replace PACO2 in the Enghoff modification of the original formula (Bohr–Enghoff equation) (Fig. 37.7B).


In heathy individuals, upper V Subscript upper D Sub Subscript p h y s is representative of upper V Subscript upper D Sub Subscript a w as upper V Subscript upper D Sub Subscript a l v is negligible. In normal conscious humans at rest, upper V Subscript upper D Sub Subscript p h y s is approximately 2 mL/kg (150 mL) and VT is 6–7 mL/kg of ideal body weight (assuming a VT of 450–500 mL in a 75 kg adult human), resulting in a upper V Subscript upper D Sub Subscript p h y s/VT ratio of approximately 30% [65]. Veterinary species in general have significantly larger deadspace volumes (indexed to body weight) than humans. Under normal conditions, upper V Subscript upper D Sub Subscript a w remains relatively constant, however, VT can change for a variety of reasons (e.g., thermoregulation, excitement, and acid–base disturbances) and therefore alter the relative amount of deadspace per VT. As such, it is important to consider the deadspace volume as well as VT indexed to ideal body weight, particularly as it relates to both anesthetic equipment and mechanical ventilation settings. In an experimental setting, unsedated normal tracheostomized dogs breathing quietly through a standard endotracheal tube had a upper V Subscript upper D Sub Subscript p h y s of 5.9 mL/kg [17]. In conscious healthy horses and cows breathing through a face mask, the Bohr–Enghoff upper V Subscript upper D Sub Subscript p h y s (calculated using a correction factor for the added deadspace represented by the facemask) was about 5.2 and 3.7 mL/kg [25]. Recent observations in anesthetized dogs receiving mechanical ventilation have confirmed that upper V Subscript upper D Sub Subscript a w estimated by volumetric capnography is substantially larger in the canine species (6.5–7.6 mL/kg) than the upper V Subscript upper D Sub Subscript a wcalculated using the single‐breath nitrogen washout test (Fowler’s method) in humans (2 mL/kg) [65,69,70]. Although some of the measured differences in deadspace between humans and animals can be attributed to the use of the Bohr–Enghoff equation, which overestimates the upper V Subscript upper D Sub Subscript p h y s/VT ratio, the use of this method likely did not have a major influence because measurements were obtained under conditions where alveolar deadspace, shunt, and V̇A/Q̇ mismatch were minimal (standing horses and cows, healthy conscious and anesthetized dogs) [73]. Because of differences in upper V Subscript upper D Sub Subscript p h y s between animal species and humans, VT settings during mechanical ventilation cannot be directly extrapolated from humans to animals, as discussed further in Chapter 38.

Two graphs show carbon dioxide versus expired partial pressure variations with volumetric capnography for calculating dead space volume using Bohr and Bohr–Enghoff equations.

Figure 37.7 Graphic representation of expired carbon dioxide partial pressure changes in relation to expired VT (volumetric capnography) showing the area used to calculate deadspace volumes according to the A. Bohr and B. Bohr–Enghoff equations.


The relationship between V̇E, V̇A, and ModifyingAbove normal upper V With dot Subscript normal upper D Sub Subscript p h y s is critical to understanding the kinetics of CO2 in both health and disease. Clinically, an increase in total deadspace volume (normal upper V Subscript normal upper D Sub Subscript p h y s) can be due to a change in normal upper V Subscript normal upper D Sub Subscript a w (either physiologic due to bronchodilation or iatrogenic with artificial airways/apparatus deadspace) and/or normal upper V Subscript normal upper D Sub Subscript a l v. An increase in f with a reduction in VT, and therefore the creation of a higher normal upper V Subscript normal upper D Sub Subscript p h y s/VT ratio, is extremely common in conscious animals for a variety of reasons, including thermoregulation. In healthy animals, V̇A and as a result, PaCO2 are maintained within physiological limits through central and peripheral chemoreceptor stimulation as previously discussed. In disease states, increases in normal upper V Subscript normal upper D Sub Subscript a l v commonly occur with low pulmonary perfusion pressures secondary to a low cardiac output (CO), pulmonary thromboembolism, severe airway disease, and acute respiratory distress syndrome (ARDS) [7477]. An increase in normal upper V Subscript normal upper D Sub Subscript a l v does not necessarily impair arterial oxygenation (PaO2) if the capillary flow that bypasses ventilated alveoli is perfusing well‐ventilated lung areas. PaCO2 levels can also be maintained within normal levels when there is an increase in normal upper V Subscript normal upper D Sub Subscript a l v by increasing f or VT to maintain V̇A. Arterial blood gases (PaO2 and PaCO2) may therefore be maintained within normal ranges in awake spontaneously breathing animals with increases in normal upper V Subscript normal upper D Sub Subscript a l v. In patients with underlying disease and patients under general anesthesia, a compensatory increase in V̇A in the face of increased normal upper V Subscript normal upper D Sub Subscript a l v may not occur. In these instances, PaCO2 will rise due to a reduction in V̇A. In addition to impacting PaCO2 values, decreases in V̇A associated with an increase in ModifyingAbove normal upper V With dot Subscript normal upper D Sub Subscript p h y s may also have an impact on a patient’s oxygenation by lowering the PAO2 if inspired gases are not enriched with oxygen (Table 37.5).


Effects of altered alveolar ventilation

While changes in deadspace may not necessarily impact the ability to achieve adequate gas exchange, when V̇A is altered significant changes in PACO2 and PAO2 can occur (Fig. 37.2, Table 37.5). As previously discussed, V̇A is inversely correlated with PaCO2 as described by the alveolar ventilation equation (V̇A = K × V̇CO2/PaCO2). Hyperventilation occurs when V̇A is excessive relative to metabolic rate; as a result, PaCO2 is reduced. An increase in f, referred to as “tachypnea,” may not result in hyperventilation if a decrease in VT prevents V̇E and V̇A from increasing. Hypoventilation is present when PaCO2 rises because V̇A is low relative to V̇CO2. The effects of hypoventilation on PAO2 and PaO2 in a healthy dog breathing ambient air or 100% oxygen are illustrated in Table 37.5. In an individual breathing ambient air at sea level with normal V̇A (e.g., PaCO2 = 36 mmHg), PAO2 is predicted to be approximately 110 mmHg by the alveolar gas equation. If there is a decrease in V̇A (e.g., PaCO2 increases from 36 mmHg to 72 mmHg), PAO2 decreases from 110 mmHg to approximately 70 mmHg because of rising CO2 levels within the alveoli. Considering that the alveolar to arterial oxygen gradient (P(a‐a)O2) is 5–15 mmHg for a healthy individual breathing ambient air, PaO2 can be predicted to be decreased from 95–105 during normal ventilation to 55–65 mmHg during hypoventilation. If air is replaced by 100% oxygen in inspired gas (FIO2 = 0.97), PAO2 will be markedly increased (612 mm Hg) despite severe hypoventilation. Although P(a‐a)O2 may increase over time due to absorption atelectasis caused by elevated FIO2, PaO2 can be estimated to be approximately 500 mmHg in the presence of severe hypoventilation with an FIO2 close to 1.0.


Pulmonary mechanics


Fluctuating pressure gradients between the airway opening and the alveoli cause air to flow in and out of the lungs. The factors that contribute to these pressure gradients and the measurement of their magnitude are referred to as “pulmonary mechanics.” During spontaneous breathing, a negative pressure gradient between the airway opening (mouth, nostrils, or the interface between the breathing circuit and the endotracheal tube) and the alveoli/pleural cavity is responsible for the inflow of gas to the lungs. In anesthetized patients, a mechanical ventilator is commonly used to create a positive pressure gradient between the airway opening (endotracheal tube) and the alveoli to generate flow of gases into the lungs during inspiration. Factors that influence the development of a pressure gradient between the airway opening and the alveoli include the elasticity of the lungs, thoracic cage, and diaphragm (chest wall), in addition to the resistance to flow between these two regions. These properties determine the normal distribution of airflow within the lung and the energy expended to achieve optimal ventilation (work of breathing). Both anesthesia and disease can alter the elastic properties and resistance of the respiratory system, impacting the ability to achieve adequate alveolar ventilation. While pulmonary physical characteristics are generally measured on the whole lung in the clinical setting, regional differences in physical properties are also important in determining normal distribution of ventilation.


Pressures measured in the respiratory system are illustrated in Fig. 37.8. By convention transpulmonary pressure (PL) is the difference in pressure across the entire respiratory system, from the pressure at the airway opening (Pao) to the pleural pressure (Ppl); however, intensive care specialists and anesthesiologists often define PL as the difference between alveolar and pleural pressures (Palv−Ppl), creating some confusion in the literature [10,78]. The pressure gradient from atmospheric pressure (taken as Pao) to the pleural space (Ppl) is responsible for the movement of air to and from the lungs during spontaneous breathing. The Pao is always 0 cmH2O at 1 atmosphere throughout the respiratory cycle in non‐instrumented, conscious, and spontaneously breathing animals. With initiation of inspiration, as active muscular effort enlarges the pleural cavity through expansion of the thoracic wall and contraction of the diaphragm, Ppl becomes more negative and causes Palv to become slightly sub‐atmospheric (negative). The slightly negative pressure gradient between Pao (0 cmH2O) and Palv (e.g., −1 cmH2O) drives airflow from the mouth/nostrils to the alveoli, and lung volume increases. In contrast to inspiration, expiration is normally passive and depends on the elastic recoil of the lungs, diaphragm, and intercostal muscles, which causes Ppl to become less negative and returns the lungs to a resting position, that is, to FRC. The horse is a notable exception in that abdominal muscle contraction plays a part in normal expiratory activity, producing a biphasic mode of exhalation. As the Ppl becomes less negative, Palv may slightly increase above atmospheric pressure. Reversal of the pressure gradient during expiration (Palv > Pao) causes air to flow from the alveoli to the airway opening/atmosphere [49,79].


Table 37.5 The effects of hypoventilation on gas exchange in a dog breathing ambient air or 100% oxygen.
















Normal ventilation, ambient air
(PaCO2 = 36 mmHg and FIO2 = 0.21)
Hypoventilation, ambient air
(PaCO2 = 72 mmHg and FIO2 = 0.21)
Hypoventilation, 100% oxygen
(PaCO2 = 72 mmHg and FIO2 = 0.97)
PAO2 = (760–47) × 0.21 – 40a
PAO2 = 110 mmHg
PAO2 = (760–47) × 0.21–80a
PAO2 = 70 mmHg
PAO2 = (760–47) × 0.97−80a
PAO2 = 612 mmHg
PaO2 = 95 to 105 mmHgb PaO2 = 55 to 65 mmHgb PaO2 = 450 to 520 mmHgc

a PAO2 = (PB–PH2O) × FIO2 − (PACO2/R) where PAO2 is the oxygen partial pressure in alveolar gas, PB is the local barometric pressure (760 mmHg at sea level), upper P Subscript upper H 2 upper O is the water vapor pressure after humidification of inspiratory gases (47 mmHg), FIO2 is the inspired oxygen fraction (0.21 for ambient air and 0.97 mmHg for 100% oxygen), and the second term is calculated by considering PACO2 as equal to PaCO2, and dividing it by the respiratory quotient (0.9 in healthy dogs) [43].


b PaO2 levels assuming a normal alveolar to arterial oxygen gradient for ambient air (P(a‐a)O2 = 5 to 15 mmHg).


PaO2 levels considering that the use of 100% in inspired gas increases P(a‐a)O2 due to absorption atelectasis.

A diagram of the system pressure the airway opening, alveolar pressure, transpulmonary pressure, elastic recoil pressure, pleural pressure, pressure at the body surface, and pressure across the chest wall.

Figure 37.8 Diagrammatic representation of pressures (white boxes) and of pressure gradients (gray boxes) measured across the respiratory system (see text for explanation).


Source: Adapted from Loring et al. [78].


The pressure difference between the airway opening and the pleural space, PL (Fig. 37.8), can be measured using a differential pressure transducer connected to the airway opening to measure Pao (face mask or endotracheal tube) and to an esophageal balloon placed in the thoracic esophagus to provide a surrogate measure of Ppl. The change in lung volume (or VT) can be measured using a spirometer, a body plethysmograph, or a pneumotachometer [10].


The pressure gradient between the alveoli and the pleural cavity (Palv−Ppl) is traditionally defined as elastic recoil pressure of the lung (Pel(L)) (Fig. 37.8 and 37.9) [78]. In spontaneously breathing subjects, Pel(L) measured at the end of inspiration provides an estimate of the lung’s ability to deflate/return to its resting position (FRC). In anesthetized individuals receiving positive‐pressure ventilation, Palv−Ppl provides an assessment of the positive pressure applied to the lung tissue per se, excluding the effects of the chest wall and abdomen [80].

A graph shows the pressure versus volume of the fluctuations in alveolar and pleural pressures throughout the respiratory cycle.

Figure 37.9 Changes in lung volume, alveolar, and pleural pressures during spontaneous breathing. Note that difference between alveolar and pleural pressure at the end of inspiration (elastic recoil pressure of the lung) may also be referred to as “transpulmonary pressure” in some literature.


Source: Ewart [79], Elsevier.


In spontaneously breathing animals, the relationship between change in pleural pressure (∆Ppl) and the resultant change in lung volume (∆V) is known as “respiratory system compliance” (CRS) or “total compliance” [9,61].


normal upper C Subscript upper R upper S Baseline equals StartFraction upper Delta normal upper V left-parenthesis normal upper L right-parenthesis Over upper Delta normal upper P Subscript p l Baseline left-parenthesis c m upper H 2 normal upper O right-parenthesis EndFraction

As shown by the formula above, CRS describes the ability of the lungs to distend in response to a change in pleural pressure. Compliance provides a measure of how stiff the lung is and is inversely correlated with elastance, that is, the force causing the lungs to recoil to FRC. CRS is also known as “total compliance” because both the lungs and chest wall (thoracic wall and diaphragm) provide an elastic resistance to lung expansion on inspiration. However, in spontaneously breathing animals, the contribution of the latter to the total respiratory system compliance is not captured when intrapleural pressures are measured due to the effort exerted by the inspiratory muscles. When the chest wall and diaphragm are partially or completely relaxed (and do not contribute any effort to breathing), however, as often occurs during general anesthesia, they become an important contributor to the elastic resistance to inspiration and total compliance (CRS). During general anesthesia, the relationship of CRS to the individual compliance of the lungs (CL) and chest wall (CCW) is additive, because the lungs and chest wall are arranged concentrically and can be expressed as:


StartFraction 1 Over normal upper C Subscript upper R upper S Baseline EndFraction equals StartFraction 1 Over normal upper C Subscript normal upper L Baseline EndFraction plus StartFraction 1 Over normal upper C Subscript upper C upper W Baseline EndFraction

During positive‐pressure ventilation, the pressure gradient that drives gas into the lungs is no longer negative and is determined by the difference between airway pressure measured at end‐inspiration and end‐expiration (∆Paw). Therefore, in anesthetized patients receiving mechanical ventilatory support, CRS is measured as the ratio between change in lung volume ∆V (that is the VT delivered by the ventilator) and the change in airway pressure (∆Paw) during a mechanical breath:


normal upper C Subscript upper R upper S Baseline equals StartFraction upper Delta normal upper V left-parenthesis normal upper L right-parenthesis Over upper Delta normal upper P Subscript a w Baseline left-parenthesis c m upper H 2 normal upper O right-parenthesis EndFraction

Prior to the advent of spirometry, in anesthetized patients receiving positive‐pressure ventilation, airway pressures at end‐inspiration and end‐expiration were used for pressure determinations, and ventilator settings (volume displaced by the bellows) were used for volume calculations. As further described in Chapter 38, with the use of modern anesthesia ventilators incorporating built‐in flow sensors (built‐in spirometry) or with the use of stand‐alone multiparameter monitors incorporating flow sensors that are placed between the endotracheal tube and the breathing circuit (near patient spirometry), more accurate determination of changes in volume and pressure can be obtained during mechanical ventilation [81,82]. The difference in how CRS is measured in spontaneously breathing versus animals receiving positive‐pressure ventilation is an important concept for the veterinary clinician as the contribution of the different components (lung and/or chest wall) to total compliance needs to be considered when interpreting values and when implementing ventilatory support strategies.


Compliance is further characterized as either dynamic, static, or quasistatic. In spontaneously breathing animals, dynamic compliance describes changes in lung volume per unit change in pleural pressure in the presence of airflow. If the patient is receiving mechanical ventilation in a volume‐controlled mode without an inspiratory pause (period of zero flow at the end of inspiration), then dynamic compliance is measured as the change in lung volume per unit change in airway pressure (peak inspiratory pressure minus end‐expiratory pressure) (Fig. 37.10A). Dynamic CRS is altered by changes in the elastic properties of the respiratory system and by changes in airway resistance (Raw). Static and quasistatic CRS describes changes in lung volume per unit change in pressure during a brief pause at end‐inspiration (zero airflow). Because patient cooperation is required, static compliance measurements are often performed in anesthetized animals receiving mechanical ventilatory support with an inspiratory pause (Fig. 37.10B) [30,8385]. The pause at end‐inspiration, before passive expiration begins, must be long enough to allow airflow to equilibrate between alveoli with faster and slower filling rates, the latter reflective of areas with heightened resistance to airflow that may be increased during pathological conditions (e.g., bronchitis/pneumonia in small animals and small airway disease in horses) [84,85]. If the duration of the inspiratory pause is between 0.5 and 2 s, frictional resistance imposed by the airways may impact measurements in humans; therefore compliance measurements are better defined as quasistatic [84,85]. Once gas flow distribution has been completed, that is, the resistive properties of the respiratory system are overcome, the ratio between VT and the change in airway pressure (plateau minus end‐expiratory pressure) reflects solely the elastic properties of the respiratory system (static or quasistatic CRS) (Fig. 37.10C). Lungs develop low static compliance (become stiffer) with a reduction in lung volume, such as occurs with regional atelectasis, pulmonary edema, or fibrosis. In the case of dynamic compliance, increases in Raw can contribute to decreases in compliance measurements. For example, asthma (heaves, recurrent airway obstruction) in horses and asthma (bronchopulmonary disease) in cats decreases dynamic lung compliance via increased Raw [86,87].

Four graphs of the lung volume, airflow, and airway pressure variations in anesthesia ventilation techniques with no pause, with pause, higher gradient, and increased gradient.

Figure 37.10 Diagrammatic representation of changes in lung volume (tidal volume), flow, and airway pressure measured at the distal end of an endotracheal tube in a normal anesthetized individual during: A. Volume‐controlled ventilation (VCV) without an inspiratory pause. B. VCV with an inspiratory pause (period of zero flow at end‐inspiration). C. During constant volume ventilation, an increase in the gradient between plateau pressure (Pplat) and end‐expiratory pressure occurs with a decrease in static or quasistatic CRS. D. An increase in the gradient between peak inspiratory pressure (Ppeak) and Pplat occurs with an increase in Raw.


As previously mentioned in this section, for gas to flow into the lungs, a pressure gradient must be developed to overcome, in addition to the elastic resistance, the nonelastic resistance of the respiratory system. The relationship between the pressure gradient and gas flow illustrated in Fig. 37.11A is analogous to a fundamental principle of physics, referred to as Ohm’s law, wherein voltage (equivalent to pressure gradient along a tube) is proportional to current (equivalent to gas flow) multiplied by resistance [88].


upper V o l t a g e equals upper C u r r e n t times upper R e s i s t a n c e

Or in terms of gas flow:


upper Delta normal upper P equals upper F l o w r a t e times upper R e s i s t a n c e

Rearranging Ohm’s law to determine resistance:


upper R e s i s t a n c e equals StartFraction upper Delta normal upper P Over upper F l o w upper R a t e EndFraction

According to the Hagen–Poiseuille equation, laminar gas flow through an unbranched straight tube is proportional to the pressure gradient across the tube and the fourth power of the radius of the tube, and inversely proportional to the viscosity of the gas and length of the tube:


upper F l o w r a t e equals StartFraction upper Delta normal upper P times pi times left-parenthesis r a d i u s right-parenthesis Superscript 4 Baseline Over 8 times v i s c o s i t y times l e n g t h o f t u b e EndFraction
Two graphs show delta p versus the flow of unbranched tube laminar flow with higher velocity at center, turbulent flow with nonlinear deltaP and velocity relationship.

Figure 37.11 A. Diagrammatic representation of laminar flow through an unbranched tube and of the linear relationship between the pressure gradient across a tube (∆P) and flow velocity during laminar flow. During laminar flow, molecules of a fluid (gas or liquid) are moving in a smooth and streamlined pattern with a greater velocity at the center of the tube. The relationship between the pressure gradient developed (∆P), that is, the drop in pressure as gas flows down an unbranched tube, and the flow rate follows a linear pattern [89,90]. Because the pressure gradient equals resistance to gas flow, resistance (R) can be calculated as R = ∆P/flow rate. B. Diagrammatic representation of turbulent flow through an unbranched tube and of the nonlinear relationship between ∆P and flow velocity during turbulent flow (see text for explanation).


Source: Adapted from Mitchell and Cheesman [89].



By combining Ohm’s law and the Hagen–Poiseuille equation (substituting Hagen–Poiseuille’s determinants of flow into Ohm’s law), the resistance to laminar gas flow can be established:


upper R e s i s t a n c e equals StartFraction 8 times v i s c o s i t y times l e n g t h o f t u b e Over pi times left-parenthesis r a d i u s right-parenthesis Superscript 4 Baseline EndFraction

Resistance to laminar flow therefore increases with an increase in the tube length or a reduction in tube radius. The significance of this equation for the anesthetist is the impact of the diameter of a patient’s airway on the resistance to gas flow. An increase in resistance can result from a variety of conditions such as bronchospasm, congenital or acquired anatomic abnormalities in the airway, and/or the presence of mucus, exudates, foreign bodies, or tumors within the airway lumen [89,90]. If a narrow endotracheal tube is used in a patient with an already increased airway resistance due to respiratory disease (e.g., tracheal collapse or brachycephalic airway syndrome), there may be a dramatic increase in resistance to airflow during anesthesia with spontaneous ventilation. For example, if the diameter of the upper airway is reduced by 50% due to pathology or secondary to the placement of a small endotracheal tube, the Raw goes up 16‐fold. Of note, with laminar flow, viscosity is the only gas property to influence resistance.


While the above relationship between gas flow, pressure gradient, and resistance is valid during laminar flow, when flow rate exceeds a critical velocity, it becomes turbulent as gas molecules swirl and turn in a chaotic pattern rather than in an orderly manner. In this circumstance, the relationship between the pressure gradient as gas flows through a straight tube (∆P) and the flow rate is no longer linear. Fig. 37.11B shows the physics of turbulent flow. In this case, ∆P will depend on gas density and the squared flow as follows [89,90]:


upper Delta normal upper P equals c o n s t a n t times g a s d e n s i t y times f l o w squared

With turbulent flow, the change in pressure is inversely proportional to the fifth power of the radius of the tube (Fanning equation); therefore, airway radius has an even greater impact on air flow than with laminar flow [91]. In a straight unbranched tube, the transition from laminar flow to turbulent flow can be estimated by the Reynold number (Re), a nondimensional number that is derived from gas velocity, tube diameter, gas density, and gas viscosity.


upper R e equals StartFraction l i n e a r g a s v e l o c i t y times t u b e d i a m e t e r times g a s d e n s i t y Over g a s v i s c o s i t y EndFraction

As the Reynolds number increases above 2000, air flow becomes progressively more turbulent. While airway resistance and its determinants are generally explained in terms of laminar flow, the structure of airways results in a mix of laminar and turbulent flow in the major airways. In addition to the variables included in calculating the Reynolds number, branching and/or irregularities in the tube predispose to turbulent flow. In general, resistance to gas flow is significantly greater with turbulent flow relative to laminar flow and turbulent flow is dependent on gas density and not viscosity. Because flow may become turbulent during pathological conditions that include narrowing/partial obstruction of the airways, incorporating helium, a gas with less density relative to oxygen or air, as a carrier gas with oxygen (mixture of 70% helium and 30% oxygen) may reduce resistance to gas flow [92,93]. As gas flow is usually laminar in the distal airways (and therefore not influenced by gas density), helium, which has a viscosity similar to air, may be less useful in animals with mild‐to‐moderate bronchoconstriction of the distal airways but it may have a positive impact in the presence of severe bronchospasm affecting the whole bronchial tree, as gas flow is likely turbulent under these circumstances [89]. In anesthetized horses, an alveolar recruitment maneuver with a mixture of 70% helium and 30% oxygen increased dynamic CRS and improved pulmonary oxygen exchange (decreased P(a‐a)O2) when compared to 100% oxygen [93]. However, dynamic CRS is altered by the resistive and elastic properties of the respiratory system, and it remains to be demonstrated that the use of helium as a carrier gas would improve pulmonary mechanics by reducing resistance to gas flow in horses [93].


During spontaneous ventilation, the relationship between the pressure gradient across the respiratory system during inspiration, that is, the pressure at the airway opening (Pao) minus the pleural pressure (Ppl) and the rate of inspiratory airflow (usually expressed in liters per second, L/s) is known as Raw (expressed in cmH2O/L/s) [61,79].


normal upper R Subscript a w Baseline equals StartFraction left-parenthesis normal upper P Subscript a o Baseline minus normal upper P Subscript p l Baseline right-parenthesis Over upper F l o w r a t e EndFraction

Airway resistance can be calculated during mechanical ventilation if using a volume‐controlled mode with an inspiratory pause during anesthesia (Fig. 37.10D). Considering that plateau pressure (Pplat) recorded at the end of an inspiratory pause is the pressure that reflects the elastic properties of the respiratory system, while peak inspiratory pressure (Ppeak) is the pressure that is necessary to overcome both the frictional resistance imposed by the airways (resistance) and the elastic properties of the respiratory system, Raw is calculated as the gradient between Ppeak and Pplat, divided by the flow rate [84,85]:


normal upper R Subscript a w Baseline equals StartFraction left-parenthesis normal upper P Subscript p e a k Baseline minus normal upper P Subscript p l a t Baseline right-parenthesis Over upper F l o w r a t e EndFraction

In conscious animals, measurement of Raw can be obtained by simultaneous determination of instantaneous airflow with a pneumotachometer connected to the airway opening (mouth or nostrils) via a facemask and of the gradient between Pao and Ppl (estimated by an esophageal balloon catheter), using a differential pressure transducer. The upper airways including the nasal cavity, pharynx, and larynx are major determinants of resistance to airflow within the respiratory system, generally contributing over 50% of the total Raw [79]. Due to the extensive branching of the airways and dramatic increase in total airway area toward the periphery of the lung, despite the narrow radius, airflow velocity in bronchioles is very low and follows a laminar pattern. Therefore, the relative contribution of the small airways and bronchioles to total Raw is low (< 10%) unless marked lower airway disease/bronchospasm is present [79]. As with lung compliance, resistance to airflow changes with lung volume. As lung volume decreases, Raw increases, with dramatic increases occurring at lung volumes below FRC.


Presence of turbulent flow and increased Raw directly impact the work of breathing, which is the energy spent by respiratory muscles (measured in joules) for air to flow in and out of the lungs. Work of breathing is measured as the product of pressure changes across the respiratory system (Pao − Ppl in spontaneously breathing animals) and the volume of gas moved (VT) [89,90]. Because inspiration is an active process that involves contraction of the diaphragm and chest wall muscles, most of the work done occurs during inspiration [89,90]. Respiratory work is further divided into elastic work (required to overcome the recoil of the lung) and resistive work (required to overcome the frictional opposition or resistance to airflow) [89,90]. As is discussed in Chapter 38, turbulent flow and increased Raw are likely to be present in dogs with brachycephalic airway syndrome or collapsed trachea and horses with severe bronchospasm secondary small airway disease (heaves). The consequent increase in the respiratory work may lead to fatigue of inspiratory muscles, therefore, mechanical ventilatory support may be required in these patients.


Distribution of ventilation


The distribution of inspired gases during inspiration is not completely homogenous throughout the lung, with gravity playing a major role in regional pulmonary ventilation. Specifically, due to the weight of the lung in the thorax, Ppl is more negative (sub‐atmospheric) in the uppermost part of the thorax relative to the lowermost portion and the negative pressure gradient between the alveoli and the pleural cavity (Palv − Ppl) is greater in dorsal lung compared to ventral lung areas. Therefore, the average alveolar size is larger in the uppermost areas and smaller in the lowermost areas of the lung at end‐expiration (Fig. 37.12A) [94,95]. Since larger alveoli have lower compliance (they are less distensible), they expand less on inspiration, and air preferentially enters the more compliant lowermost alveoli (Fig. 37.12B), producing a vertical gradient of ventilation distribution in standing animals breathing quietly [9698]. This tendency for preferential ventral ventilation in the lung may also be associated with regional chest wall and diaphragmatic movement. During anesthesia, the distribution of ventilation becomes more uneven and may even reverse so that the uppermost lung of a laterally recumbent horse is receiving most of the ventilation.


Local resistance to air flow and compliance are the two major determinants of regional distribution of ventilation [79] (Fig. 37.13). Alveoli within regions with normal resistance and compliance completely fill during slow and fast tidal breathing, while alveoli that are poorly complaint due to inflammation/fluid accumulation in the interstitium (e.g., in pneumonia) only partially fill during inspiration. If there is increased resistance to airflow due to narrowing of the small airways caused by mucus, bronchoconstriction, or foreign material, these alveolar units take longer to fill and empty during tidal breathing and are referred to as “slow” alveoli. Slow alveoli also tend to be under‐distended during inspiration (less ventilated than perfused), especially at faster respiratory frequencies [79]. Slow alveoli contrast with alveoli that completely fill regardless of the breathing pattern (“fast alveoli”). Uneven distribution of ventilation, leading to areas of low V̇A/Q̇ and gas exchange impairment (lower‐than‐expected PaO2 values) occur in lung disease due to areas with poor compliance or increased resistance to airflow.

Two graphs show alveolar size at end-expiration alveoli in upper lungs are less flexible due to negative pleural pressure. Smaller alveoli in lower regions expand at the end of inhaling.

Figure 37.12 Relative alveolar size at endexpiration and endinspiration and distribution of ventilation in standing horse. A. Endexpiration: In the uppermost lung regions alveoli are close to their maximum size (i.e., are less compliant) because Ppl is more sub‐atmospheric (negative) in dorsal regions. In the lowermost lung regions, Ppl is less negative, alveoli are more compliant because Ppl is less sub‐atmospheric. B. End‐inspiration: As Ppl become more negative causing the lungs to expand, ventilation (inspiratory flow) is directed preferentially to smaller/more compliant alveoli located in lowermost and intermediate lung regions.

Two diagrams of the sizes of alveoli at the end of expiration and inspiration are compared during slow and rapid breathing in alveoli with different levels of resistance and compliance A, B, and C.

Figure 37.13 A. Relative alveolar size at end‐expiration and end‐inspiration during slow breathing versus more rapid breathing in alveoli with varying resistance and compliance. Alveoli labeled A represent normal resistance and compliance; alveoli labeled B represent high resistance and normal compliance; and alveoli labeled C represent normal resistance and low compliance. B. Graphical representation of changes in pleural pressure and alveolar size during slow breathing and more rapid breathing in alveoli with varying resistance and compliance (A, B, and C). See text for explanation.


Source: Adapted from Robinson [49].


Pulmonary perfusion


The pulmonary circulation is a low‐pressure system composed of highly compliant arterial vessels that offer low resistance to blood flow. Because pulmonary arterial tree vessels are relatively thin‐walled and compliant, the pulmonary circulation can accommodate large increases in blood flow without an appreciable increase in mean pulmonary arterial pressure (MPAP) under physiological conditions. One notable exception is horses, where MPAP increases from 25–30 mmHg at rest to values above 80 mmHg during galloping because the pulmonary vasculature cannot dilate to accommodate the large increase in pulmonary blood flow/CO that occurs during high‐intensity exercise [99]. The pulmonary hypertension caused by the increase in pulmonary blood flow is considered a major factor that contributes to exercise‐induced pulmonary hemorrhage in equine species [100]. The extensive branching of the pulmonary arterial tree increases the vascular surface area available for gas exchange. Although this is followed by a progressive reduction in the diameter of arterial vessels, when the multiple arterial branches are arranged in parallel, the total cross‐sectional area of the pulmonary arterial tree is greatly increased; hence, vascular resistance is lower in the pulmonary than in the systemic circulation even though it accepts the same volume of blood per unit of time. Interestingly, there are differences among species, with horses having higher pulmonary artery pressures at rest than humans and dogs [101,102]. Typically, MPAP values in resting conscious horses are in the range of 25–30 mmHg while in dogs MPAP values are approximately 15 mmHg [101103]. Higher pulmonary artery pressure values observed in large animal species are necessary to overcome the large vertical hydrostatic pressure gradient and provide perfusion to the uppermost areas of the lungs.


In the absence of intracardiac shunting, the pulmonary blood flow generated by the right ventricle equals the aortic blood flow generated by the left ventricle. The total blood flow to the lungs (Q̇T), is determined by the gradient between arterial MPAP and left atrial pressure (LAP) and by pulmonary vascular resistance (PVR), as follows:


ModifyingAbove normal upper Q With dot Subscript normal upper T Baseline equals StartFraction left-parenthesis upper M upper P upper A upper P minus upper L upper A upper P right-parenthesis Over upper P upper V upper R EndFraction

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 1, 2025 | Posted by in SUGERY, ORTHOPEDICS & ANESTHESIA | Comments Off on Respiratory Physiology and Pathophysiology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access